Objectives The purpose of this study was to assess whether the presence and extent of
fibrosis changes over time in patients with nonischemic, dilated cardiomyopathy (DCM) …

Introduction Dilated cardiomyopathy (DCM) is associated with significant morbidity and
mortality. Contrast-enhanced cardiac MRI (CE-CMR) can detect potentially prognostic …

Importance Risk stratification of patients with nonischemic dilated cardiomyopathy is
primarily based on left ventricular ejection fraction (LVEF). Superior prognostic factors may …

Background—We conducted a prospective longitudinal study to investigate the yet unknown
clinical significance of myocardial fibrosis in patients with non–ischemic cardiomyopathy …

Background The presence of focal myocardial fibrosis, also called scar or replacement
fibrosis, detected with late gadolinium enhancement (LGE) cardiovascular magnetic …

Background: Myocardial fibrosis, identified by late gadolinium enhancement cardiovascular
magnetic resonance, predicts outcomes in chronic heart failure (HF). Its prognostic …

Objectives Heart failure with preserved ejection fraction (HFpEF) is a syndrome with
significant clinical heterogeneity. Myocardial fibrosis has been considered a common …

Background The use of cardiac magnetic resonance imaging (c-MRI) in risk stratification for
clinical outcomes of patients with ischemic cardiomyopathy (ICM) remains low. This …

Objectives: The purpose of this study was to investigate diffuse myocardial fibrosis in
patients with systolic heart failure (SHF) and in patients with heart failure with preserved …

Background—Late gadolinium enhancement-cardiac magnetic resonance is increasingly
performed in patients with systolic dysfunction. Numerous patterns of fibrosis are commonly …